Summary of pneumococcal immunisation policy

Public Health England

  • Pneumococcal vaccine is recommended for:
    • infants as part of the routine childhood immunisation programme
    • all those aged 65 years and over
    • all those aged 2 months and over in the clinical risk groups as set out in the table
  • Previously unvaccinated children and adults requiring splenectomy or commencing immunosuppressive treatment may be at an increased risk of pneumococcal disease and should be vaccinated according to the schedule for this specific risk group
  • There are two types of pneumococcal vaccine—23-valent pneumococcal polysaccharide vaccine (PPV) and 13-valent pneumococcal conjugate vaccine (PCV)
  • Primary care staff should identify patients for whom vaccine is recommended and use all opportunities to ensure that they are appropriately immunised, for example:
    • when immunising against influenza
    • at other routine consultations, especially on discharge after hospital admission
  • Most healthy adults develop a good antibody response to a single dose of polysaccharide vaccine by the third week following immunisation

Register to view this page

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Log in

Need help? Email us